• Slider Image
  • Slider Image
  • Slider Image

In the Press

June 14, 2018

Healthcast: Pregnant with cancer

Dr. Parag Sanghvi and colleagues came up with a plan that let a pregnant cancer patient tonsil cancer keep her baby.

June 8, 2018

Chemo bath: Wiping out cancer where recurrence used to be a probability

Dr. Andy Lowy says that HIPEC is increasing cure rates of several cancer of abdominal organs, and has been successful for patients with cancers of the appendix, colon, ovaries, stomach and mesothelioma.

June 5, 2018

Building the Alpha Stem Cell CLinic Network

Dr. Catriona Jamieson and Mary Donohoe describe in detail how the resulting network of Alpha Stem Cell Clinics has significantly advanced the idea of stem cells and regenerative medicine from much-touted promise to practice.

June 3, 2018

Healthy Living: New study shows most women with early breast cancer don’t need chemo

A major new study shows many breast cancer patients in the early stages of the disease can safely skip chemotherapy, with input from Dr. Richard Schwab.

June 3, 2018

A Love of Science Leads to an Esteemed Career in Cancer Research for Razelle Kurzrock, MD

The ASCO Post Narratives Special Issues features a spotlight on Dr. Razelle Kurzrock.

May 31, 2018

Stem cell banking an unclear path for regenerative medicine: 4 notes

Dr. Dan Kaufman gave his input on stem cell banking research.

May 30, 2018

Frontline Cancer: Are you in for All of Us Research Program?

Cancer scientists and doctors have been pushing and practicing personalized medicine for several years, the idea behind the All of Us Research Program, and nowhere more so than at Moores Cancer Center at UC San Diego Health, says MCC Director Dr. Scott Lippman.

May 24, 2018

Frontline Ibrutinib Plus Obinutuzumab Improves PFS in Phase III CLL Trial

Dr. Michael Choi commented on the initial Icll-07 Filo study data in an Insights segment on OncLive.

May 17, 2018

New Blood Test Rapidly Detects Signs of Pancreatic Cancer

A new diagnostic test developed by researchers at UC San Diego shows promise for detecting pancreatic disease earlier.

May 10, 2018

We Need You: Join All of Us to Advance Precision Medicine

UC San Diego Health researchers call for volunteers to participate in landmark precision medicine research effort, including Dr. Razelle Kurzrock.

May 7, 2018

Non-Aspirin NSAIDs Offer No Survival Advantage in Metastatic RCC

This is the first such study in this group,with findings running counter to prior research in other cancers, with senior author of the study Dr. Rana McKay.

April 25, 2018

Breathe easier with lung cancer screenings

UC San Diego Health established a new lung cancer screening program to help current and former smokers determine their risk for lung cancer. The program is led by Dr. Mark Onaitis.

April 20, 2018

Keytruda Performs Well in Latest Lung Cancer Clinical Trials

The immunotherapy drug has been successful in treating other cancers and the latest trials provide hope for people battling lung cancer. The piece features Dr. Sandip Patel.

April 12, 2018

What You Need to Know About Head and Neck Cancer

Cancer.Net has a new blog about Head and Neck Cancer written by Dr. Kathryn Gold.

April 9, 2018

Cutting-edge cancer drug hobbled by diagnostic test confusion

Physicians struggle to identify which patients are likely to respond to a recently approved therapy, with input from Dr. Razelle Kurzrock.

April 5, 2018

Bryce Olson Wants To Raise Awareness About Precision Medicine. His Rallying Cry: 'Sequence Me'

Bryce Olson's story and collaboration with UC San Diego Moores Cancer Center is told in Forbes, featuring his collaboration team that includes Ida Deichaite, PhD, Director of Industry Relations, Pablo Tamayo, PhD, and Christina Jamieson, PhD.

April 2, 2018

Surprise! Medical Research a Big Winner in New Federal Budget

Despite the president’s threats to cut funding, Congress approved budget increases for cancer, Alzheimer’s, and other medical research. The article features research by Dr. Ezra Cohen.

April 2, 2018

Even DNA that Doesn’t Encode Genes Can Drive Cancer

A trove of previously overlooked genetic mutations play a role in cancer, providing nearly 200 new opportunities for molecularly targeted therapeutics, in a study by senior author Trey Ideker, PhD.

March 28, 2018

Local Realtors and restaurants team up for fundraiser

Local real estate agents and Conejo Valley restaurants are participating in an April effort to raise funds for research into a rare cancer of the gastrointestinal tract, one that has afflicted a 2017 Westlake High School graduate over the past year, and will support research being done by Dr. Jason Sicklick.

March 25, 2018

Expert Point of View: Ezra Cohen, MD, PhD

Discussant for the abstract, Dr. Ezra Cohen pointed out that although this subgroup may be responsive to checkpoint inhibition, it may not necessarily be anti–programmed cell death protein 1 (anti–PD-1) therapy.

March 20, 2018

Dr. Sacco on Ongoing Trials for Chemoradiation in Head and Neck Cancer

Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses ongoing trials investigating chemoradiation for patients with head and neck cancer.

March 16, 2018

Comprehensive Breast Health Center Expands at UC San Diego Health

The Comprehensive Breast Health Center is located within the Koman Family Outpatient Pavilion at UC San Diego Health, and the facility offers women and men new options for breast cancer care.

March 9, 2018

Tissue-agnostic cancer drug pipeline grows, despite doubts

The FDA could soon approve the first drug developed explicitly for a tissue-agnostic cancer indication, but biological complexity may limit this approach. This Nature Review Drug Discovery article features Dr. Razelle Kurzrock.

» More Press

2019 Symposium

The 15th Moores Cancer Center Industry/Academia Translational Oncology Symposium will be held on Thursday, February 21, 2019.

2018 Symposium

The 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 22, 2018. See the Agenda here.

Duane Roth Award Lecture
Engineered T-Cells: The Sky is the Limit

Carl June, MD

Richard W. Vague Professor Of Immunotherapy
Perelman School Of Medicine
University Of Pennsylvania

Keynote Speaker
A New Model for Translational Research in the Nonprofit Sector

Peter Schultz, PhD

Chief Executive Officer
California Institute for Biomedical Research

Opening Remarks
Ida Deichaite, PhD, UC San Diego Moores Cancer Center

Mutational Signatures for Cancer Treatment and Cancer Prevention
Ludmil Alexandrov, PhD, UC San Diego Moores Cancer Center

Duane Roth Award Presenter
David Brenner, MD, Dean, UC San Diego SOM & Health Sciences

Junior Scientist Presentation: Dual PI3K/BRD4 Inhibition as a Novel Therapeutic Strategy for Hepatocellular Carcinoma
Adam Burgoyne, MD, PhD, UC San Diego Moores Cancer Center

The New Generation of Antibody Drug Conjugates: Intersection of Target and Payload
Julia Coronella, PhD, Tanabe Research Labs

Moores Cancer Center Overview
Ezra Cohen, MD, UC San Diego Moores Cancer Center

Symposium Introduction
Ida Deichaite, PhD, UC San Diego Moores Cancer Center

In silico drug discovery of dual inhibitors of combinatorial synthetic lethality inhibitors in the era of precision medical oncology; proof of concept
Donald Durden, MD, PhD, UC San Diego Moores Cancer Center

Role of neutrophil-mediated inflammation in colorectal cancer
Napoleone Ferrara, MD, UC San Diego Moores Cancer Center

A Personalized Cancer Immunotherapy Paradigm: Simple solutions to address complex options for patients
Priti Hedge, PhD, Genentech

The Next Wave: BCMA Targeted CAR-T Cells for Multiple Myeloma
Kristen Hege, MD, Celgene

Welcome Remarks
Pradeep Khosla, PhD, Chancellor, UC San Diego

Moores Cancer Center Introduction
Scott Lippman, MD, UC San Diego Moores Cancer Center

Inhibition of Difficult to Drug Tumor Cell and Immuno-Oncology targets with Next Generation Antisense Inhibitors
Robert MacLeod, PhD, Ionis Pharmaceuticals

Systematic Mapping of Genetic Vulnerabilities in Cancer via Novel CRISPR-Cas9 Screening Methodologies
Prashant Mali, PhD, UC San Diego Moores Cancer Center

Patient Advocacy Presentation
Brian McCloskey, Patient Advocate

Targeting PARP in Prostate Cancer: Promise and Pitfalls
Rana McKay, MD, UC San Diego Moores Cancer Center

Patient Advocacy Presentation
Bryce Olson, Patient Advocate

Gene Control Approach to Manipulate Cell State: Sensitizing Cancer Cells to Antibody-mediated Attack
Dave Orlando, PhD, Syros Pharmaceuticals

Killing Cancer Stem Cells in Brain Cancer
Jeremy Rich, MD, UC San Diego Moores Cancer Center

2017 Symposium

Take a look at featured talks from the past symposium.

2015 Symposium Slideshow

Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!

2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.

The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here

Our Symposium Page

9th Symposium Featured on San Diego ABC 10 News

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press